Jami Dover Nachtsheim and Nelson Chan have been appointed to the board of directors of Affymetrix, the firm said last week in a filing with the US Securities and Exchange Commission.
Affy also said that John Young will retire from the board at the time of its annual shareholders' meeting in May.
Nachtsheim has been appointed to Affy's compensation committee and Chan to its audit committee. Each received an initial grant of 20,000 stock options.
Nachtsheim served in a variety of positions with Intel from 1980 until her retirement in 2000, most recently as corporate vice president of the sales and marketing group and director of worldwide marketing.
Chan was CEO of Magellan Navigation from 2006 to 2008. From 1992 to 2006, he served in various senior management positions with SanDisk, including most recently as executive vice president and general manager of consumer business.
Adrian Dillon will resign as executive vice president of finance and administration and chief financial officer of Agilent Technologies to become chief financial and administrative officer at Skype. He will be replaced at the beginning of April by Didier Hirsch, who currently is VP of corporate controllership and taxes and who will serve as acting CFO.
Enzo Biochem has appointed Robert Boorstein medical director of Enzo Clinical Labs, a full service clinical reference laboratory serving the metropolitan New York City medical community.
Boorstein is an associate professor of pathology at the New York University School of Medicine, Enzo said.
David U'Prichard has joined the board of directors of Ocimum Biosolutions, the firm said this week.
U'Prichard is president of Druid Consulting, and sits on the boards of Life Technologies, Oxagen, Cyclacel, and Silence Therapeutics. He is also a venture partner at Red Abbey Venture Partners.